Phil Nadeau
Stock Analyst at TD Cowen
(4.58)
# 945
Out of 4,575 analysts
769
Total ratings
51.2%
Success rate
9.8%
Average return
Main Sectors:
Stocks Rated by Phil Nadeau
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIIB Biogen | Maintained: Buy | $215 | $202.19 | +6.34% | 54 | Jul 20, 2026 | |
| SNDX Syndax Pharmaceuticals | Maintained: Buy | n/a | $20.81 | - | 21 | Jul 15, 2026 | |
| VYGR Voyager Therapeutics | Maintained: Buy | n/a | $3.10 | - | 42 | Jul 13, 2026 | |
| VRTX Vertex Pharmaceuticals | Maintained: Buy | $525 | $477.36 | +9.98% | 86 | Jul 7, 2026 | |
| NKTX Nkarta | Initiated Coverage: Buy | n/a | $2.27 | - | 1 | Jun 23, 2026 | |
| RYTM Rhythm Pharmaceuticals | Maintained: Buy | $130 | $102.10 | +27.33% | 36 | Jun 17, 2026 | |
| ELVN Enliven Therapeutics | Maintained: Buy | n/a | $52.95 | - | 17 | Jun 11, 2026 | |
| IPSC Century Therapeutics | Maintained: Buy | n/a | $2.11 | - | 4 | Jun 8, 2026 | |
| CABA Cabaletta Bio | Maintained: Buy | n/a | $2.69 | - | 15 | Jun 3, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintained: Buy | $120 | $59.33 | +102.26% | 83 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $10.39 | - | 21 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $19.02 | - | 19 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $7.05 | - | 13 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $8.69 | - | 20 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $5.22 | - | 18 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $19.73 | - | 2 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $200 | $175.77 | +13.79% | 56 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.60 | - | 27 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $16.30 | - | 6 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $7.90 | n/a | 18 | Mar 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 27 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $27.84 | n/a | 31 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.48 | n/a | 4 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $10.64 | n/a | 3 | Feb 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 → $75 | $129.31 | n/a | 44 | Feb 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $15.15 | n/a | 12 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.74 | n/a | 7 | Aug 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $3.19 | n/a | 6 | Feb 26, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $385 | $656.01 | n/a | 40 | Feb 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $4.00 | n/a | 14 | Jan 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2 → $16 | $0.0001 | n/a | 14 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $205 | $376.04 | n/a | 1 | Jul 26, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.29 | n/a | 1 | May 3, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $185 | $528.47 | n/a | 5 | Apr 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $15.68 | n/a | 1 | Aug 7, 2015 |
Biogen
Jul 20, 2026
Maintained: Buy
Price Target: $215
Current: $202.19
Upside: +6.34%
Syndax Pharmaceuticals
Jul 15, 2026
Maintained: Buy
Price Target: n/a
Current: $20.81
Upside: -
Voyager Therapeutics
Jul 13, 2026
Maintained: Buy
Price Target: n/a
Current: $3.10
Upside: -
Vertex Pharmaceuticals
Jul 7, 2026
Maintained: Buy
Price Target: $525
Current: $477.36
Upside: +9.98%
Nkarta
Jun 23, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $2.27
Upside: -
Rhythm Pharmaceuticals
Jun 17, 2026
Maintained: Buy
Price Target: $130
Current: $102.10
Upside: +27.33%
Enliven Therapeutics
Jun 11, 2026
Maintained: Buy
Price Target: n/a
Current: $52.95
Upside: -
Century Therapeutics
Jun 8, 2026
Maintained: Buy
Price Target: n/a
Current: $2.11
Upside: -
Cabaletta Bio
Jun 3, 2026
Maintained: Buy
Price Target: n/a
Current: $2.69
Upside: -
BioMarin Pharmaceutical
May 21, 2026
Maintained: Buy
Price Target: $120
Current: $59.33
Upside: +102.26%
May 12, 2026
Maintained: Buy
Price Target: n/a
Current: $10.39
Upside: -
May 11, 2026
Maintained: Buy
Price Target: n/a
Current: $19.02
Upside: -
May 11, 2026
Maintained: Buy
Price Target: n/a
Current: $7.05
Upside: -
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $8.69
Upside: -
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $5.22
Upside: -
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $19.73
Upside: -
May 5, 2026
Maintained: Buy
Price Target: $200
Current: $175.77
Upside: +13.79%
May 5, 2026
Maintained: Buy
Price Target: n/a
Current: $2.60
Upside: -
Apr 29, 2026
Maintained: Buy
Price Target: n/a
Current: $16.30
Upside: -
Mar 9, 2025
Maintained: Buy
Price Target: n/a
Current: $7.90
Upside: n/a
Nov 13, 2024
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Oct 31, 2024
Maintained: Buy
Price Target: n/a
Current: $27.84
Upside: n/a
Mar 22, 2024
Rated: Hold
Price Target: n/a
Current: $5.48
Upside: n/a
Feb 13, 2023
Downgraded: Hold
Price Target: n/a
Current: $10.64
Upside: n/a
Feb 4, 2021
Maintained: Buy
Price Target: $80 → $75
Current: $129.31
Upside: n/a
Nov 9, 2020
Reiterated: Buy
Price Target: n/a
Current: $15.15
Upside: n/a
Aug 7, 2019
Maintained: Buy
Price Target: n/a
Current: $1.74
Upside: n/a
Feb 26, 2019
Initiated Coverage: Buy
Price Target: n/a
Current: $3.19
Upside: n/a
Feb 6, 2019
Rated: Hold
Price Target: $385
Current: $656.01
Upside: n/a
Jan 17, 2019
Maintained: Hold
Price Target: n/a
Current: $4.00
Upside: n/a
Nov 2, 2018
Maintained: Buy
Price Target: $2 → $16
Current: $0.0001
Upside: n/a
Jul 26, 2018
Rated: Buy
Price Target: $205
Current: $376.04
Upside: n/a
May 3, 2016
Reiterated: Hold
Price Target: n/a
Current: $2.29
Upside: n/a
Apr 28, 2016
Reiterated: Buy
Price Target: $185
Current: $528.47
Upside: n/a
Aug 7, 2015
Reiterated: Hold
Price Target: n/a
Current: $15.68
Upside: n/a